Abstract:Amycolatopsis sp. strain TNS106 harbors a ristomycin-biosynthetic gene cluster (asr) in its genome and produces ristomycin A. Deletion of the sole cluster-situated StrR family regulatory gene, asrR, abolished ristomycin A production and the transcription of the asr genes orf5 to orf39. The ristomycin A fermentation titer in Amycolatopsis sp. strain TNS106 was dramatically improved by overexpression of asrR and a heterologous StrR family regulatory gene, bbr, from the balhimycin-biosynthetic gene cluster (BGC) utilizing strong promoters and multiple gene copies. Ristomycin A production was improved by approximately 60-fold, resulting in a fermentation titer of 4.01 g/liter in flask culture, in one of the engineered strains. Overexpression of AsrR and Bbr upregulated transcription of tested asr biosynthetic genes, indicating that these asr genes were positively regulated by AsrR and Bbr. However, only the promoter region of the asrR operon and the intergenic region upstream of orf12 were bound by AsrR and Bbr in gel retardation assays, suggesting that AsrR and Bbr directly regulated the asrR operon and probably orf12 to orf14 but no other asr biosynthetic genes. Further assays with synthetic short probes showed that AsrR and Bbr specifically bound not only probes containing the canonical inverted repeats but also a probe with only one 7-bp element of the inverted repeats in its native context. AsrR and Bbr have an N-terminal ParB-like domain and a central winged helix-turn-helix DNA-binding domain. Site-directed mutations indicated that the N-terminal ParB-like domain was involved in activation of ristomycin A biosynthesis and did not affect the DNA-binding activity of AsrR and Bbr. IMPORTANCE This study showed that overexpression of either a native StrR family regulator (AsrR) or a heterologous StrR family regulator (Bbr) dramatically improved ristomycin A production by increasing the transcription of biosynthetic genes directly or indirectly. The conserved ParB-like domain of AsrR and Bbr was demonstrated to be involved in the regulation of asr BGC expression. These findings provide new insights into the mechanism of StrR family regulators in the regulation of glycopeptide antibiotic biosynthesis. Furthermore, the regulator overexpression plasmids constructed in this study could serve as valuable tools for strain improvement and genome mining for new glycopeptide antibiotics. In addition, ristomycin A is a type III glycopeptide antibiotic clinically used as a diagnostic reagent due to its side effects. The overproduction strains engineered in this study are ideal materials for industrial production of ristomycin A.

Combinatorial Effect of ARTP Mutagenesis and Ribosome Engineering on an Industrial Strain of Streptomyces Albus S12 for Enhanced Biosynthesis of Salinomycin.

Enhanced Salinomycin Production by Adjusting the Supply of Polyketide Extender Units in Streptomyces Albus

Establishing an Efficient Salinomycin Biosynthetic Pathway in Three Heterologous Streptomyces Hosts by Constructing a 106-Kb Multioperon Artificial Gene Cluster.

Generation of high rapamycin producing strain via rational metabolic pathway-based mutagenesis and further titer improvement with fed-batch bioprocess optimization.

Cloning And Characterization Of The Polyether Salinomycin Biosynthesis Gene Cluster Of Streptomyces Albus Xm211

Conversion of the High-Yield Salinomycin Producer Streptomyces Albus BK3-25 into a Surrogate Host for Polyketide Production

Mechanism of Salinomycin Overproduction in Streptomyces Albus As Revealed by Comparative Functional Genomics

Positive Regulation of the MarR-type Regulator Slno and Improvement of Salinomycin Production by Streptomyces Albus by Multiple Transcriptional Regulation.

Enhanced Triacylglycerol Metabolism Contributes to Efficient Oil Utilization and High-Level Production of Salinomycin in Streptomyces Albus ZD11.

Comparative Transcriptome-Based Mining of Genes Involved in the Export of Polyether Antibiotics for Titer Improvement.

Direct Cloning and Heterologous Expression of the Salinomycin Biosynthetic Gene Cluster from Streptomyces Albus DSM41398 in Streptomyces Coelicolor A3(2)

Screening of high-salinomycin-yield mutants of Streptomyces albus by self-resistance methodology

Role of a Two-Component Signal Transduction System RspA1/A2 in Regulating the Biosynthesis of Salinomycin in Streptomyces Albus

SlnR is a Positive Pathway-Specific Regulator for Salinomycin Biosynthesis in Streptomyces Albus

Improvement of A21978C production in Streptomyces roseosporus by reporter-guided rpsL mutation selection.

Enhancing Solanine Production and Antifungal Activity by Streptomyces Abikoensis XH-17 Through Combined Ribosome Engineering and Post-Translational Modification

Salinomycin biosynthesis reversely regulates the -oxidation pathway in <i>Streptomyces albus</i> by carrying a 3-hydroxyacyl-CoA dehydrogenase gene in its biosynthetic gene cluster

Improving Rhamnolipids Biosynthesis in Pseudomonas Sp. L01 Through Atmospheric and Room-Temperature Plasma (ARTP) Mutagenesis

Novel Approach for Improving the Productivity of Antibiotic-Producing Strains by Inducing Combined Resistant Mutations

Daptomycin production enhancement by ARTP mutagenesis and fermentation optimization in Streptomyces roseosporus

Enhancing Ristomycin A Production by Overexpression of ParB-Like StrR Family Regulators Controlling the Biosynthesis Genes